Department of Medicine faculty have received notice of the following research, clinical trials, CME or other training awards.
[tabs style="vertical"][tab title="Sponsored research"]Robert M. Califf of Cardiology has received an award (3UL1-TR001117-02S1) from the National Institutes of Health for a project entitled "Duke CTSA (UL1): TACT Administrative Supplement." Total funding will be $449,290.
Gary M. Felker of Cardiology has received a sub-award (U10-HL084904-) through the National Institutes of Health for a project entitled "ATHENA-HF."
Geoffrey Pitt of Cardiology has received an award (1R01-HL122967-01A1) from the National Institutes of Health for a project entitled "Calmodulin regulation of Na+ channels in neurons and cardiomyocytes." Total funding will be $2,090,793.
Gillian D. Schmidler of Cardiology has received a sub-award (HHSA290201200014I) through the Oregon Health & Science University for a project entitled "Topic Refinement and Systematic Review for Catheter Ablation for Atrial Fibrillation - Technology Assessment." Total funding will be $74,509.
Deepak Voora of Cardiology has received an award (FA8650-13-2-6375) from the United States Air Force for a project entitled "Genetically Guided Statin Therapy." Total funding will be $1,175,230.
Deepak Voora of Cardiology has received an award from the AstraZeneca Healthcare Foundation for a project entitled "Development of Platelet RNA Biomarkers for the Response to Ticagrelor." Total funding will be $606,534.
Nirmish R. Shah of Hematology has received an award (1K23-HL119557-01A1) from the National Institutes of Health for a project entitled "Improving Pain in Sickle Cell Patients With Targeted Antithrombotic Therapy." Total funding will be $400,296.
Brent A. Hanks of Medical Oncology has received a sub-award (5U01-CA154967-05) through the Fred Hutchinson Cancer Research Center for a project entitled "Phase II piolot trial of an Indoleamine 2,3, diosygenase-1 (IDO1) inhibitor (INCB024360) plus a multipeptide melanoma vaccine."
Arif H. Kamal of Medical Oncology has received an award from the Cambia Health Foundation for a project entitled "Which palliative care quality measures improve patient-centered outcome?" Total funding will be $180,000.
Thomas M. Coffman of Nephrology has received a sub-award (3U24-DK076169-09) through the Georgia Regents University for a project entitled "Immune Mechanisms in Diabetic Nephropathy." Total funding will be $100,000.
Tricia Fuller (Mentor: Megan E. Clowse) of Rheumatology and Immunology has received an award from the Rheumatology Research Foundation for a project entitled "Fuller - Health Professional Online Education Grant." Total funding will be $1,200.[/tab][tab title="Industry-sponsored clinical trials"]Brett D. Atwater of Cardiology has received an award from Boston Scientific Corporation for a project entitled "Linking the Latitude Patient Registry to Medicare Claims Data." Total funding will be $49,042.
Geoffrey S. Ginsburg of Cardiology has received an award from Merck Sharp & Dohme for a project entitled "Respiratory viral infection systems biology collaboration." Total funding will be $108,777.
John K. Harrison of Cardiology has received an award from St. Jude Medical Inc. for a project entitled "Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial (PORTICO)." Total funding will be $1,005,805.
William S. Jones of Cardiology has received an award from AstraZeneca LP for a project entitled "TI-PAD I EVR." Total funding will be $74,956.
Raymond J. Kim of Cardiology has received an award from CardioCell for a project entitled "Hypoxia-grown Mesenchymal Stem Cell Heart Failure Trial [Hyp-MSC-Heart Failure Trial]." Total funding will be $297,042.
Thomas J. Povsic of Cardiology has received an award from Teva Pharmaceutical Industries, Ltd for a project entitled "DREAM-HF." Total funding will be $263,762.
Matthew W. Sherwood (Mentor: Michael A. Blazing) of Cardiology has received an award from AstraZeneca LP for a project entitled "Overview of the Duke Health Systems Acute Coronary Syndromes suggested algorithm of care." Total funding will be $7,000.
James E. Tcheng of Cardiology has received an award from Philips Healthcare for a project entitled "Philips Healthcare Research Plan for Relay Project." Total funding will be $4,000.
Manal F. Abdelmalek of Gastroenterology has received an award from Synageva BioPharma for a project entitled "A Study to Identify the Frequency of Lysosomal Acid Lipase Deficiency in At-Risk Patient Populations." Total funding will be $196,340.
Manal F. Abdelmalek of Gastroenterology has received an award from Tobira Therapeutics, Inc for a project entitled "TOBIRA 652-2-203 Efficacy and safety study of Cenicriviroc or the treatment of nonalcoholic steatohepatitis (NASH) in adult subjects with liver fibrosis" Total funding will be $201,202.
Andrew J. Muir of Gastroenterology has received an award from Roche Molecular Systems for a project entitled "RMS COL-HCV-200 – RMS " Total funding will be $11,133.
Keyur Patel of Gastroenterology has received an award from the Gilead Sciences, Inc. for a project entitled "Gilead GS-342-1553 - A randomized, open-label study to evaluate the efficacy and safety of Sofosbuvir/GS-5816 fixed dose combination – Ribavirin for 24 weeks in chronic HCV infected subjects who participated in a prior Gilead-sponsored HCV study." Total funding will be $190,190.
Patrick M. Sullivan of Geriatrics has received an award from Alion Pharmaceuticals for a project entitled "In vivo testing of lead compound for Alion pharmacueticals." Total funding will be $729,802.
David Rizzieri of Hematological Malignancies and Cellular Therapy has received an award from AbbVie Inc. for a project entitled "Phase I Study of ABT-199 in comb w/ Aza or Dec with AML patients ho are > 65 y/o." Total funding will be $964,863.
Nirmish R. Shah of Hematology has received an award from Bayer Healthcare Pharmaceuticals Inc for a project entitled "Multicenter, open-label, active-controlled, randomized study to evaluate the efficacy and safety of an age- and body-weight-adjusted rivaroxaban regimen in children with acute venous thromboembolism." Total funding will be $66,773.
Frank R. Dunphy of Medical Oncology has received an award from AstraZeneca Pharmaceuticals, LP for a project entitled "A phase III, open-label, randomized study of AZD9291 versus platinum based doubl chemotherapy for patients with locally advanced or metastatic non-small cell lung cancer." Total funding will be $336,347.
Brent A. Hanks of Medical Oncology has received an award from MedPacto, Inc for a project entitled "Investigation of TEW-7197 in Combination with Immune Checkpoint Inhibition in the BRAFV600E-PTEN-/- Melanoma Model." Total funding will be $42,565.
Michael R. Harrison of Medical Oncology has received an award from Medivation, Inc. for a project entitled "EXTEND PC: Safety and Efficacy of Exercise Training in Men Receiving Enzalutamide in Cominbation iwth Conventional Androgen Deprivation Therapy for Hormone Naive Prostate Cancer." Total funding will be $601,643.
Herbert I. Hurwitz of Medical Oncology has received an award from Novartis Pharmaceuticals Corporation for a project entitled "Modular phase II study to link tartgeted therapy to patients with pathway activated tumors: Module 7 - Ceritinig (LDK378) for patients whose tumors have aberrations in ALK or ROS1." Total funding will be $90,954.
Herbert I. Hurwitz of Medical Oncology has received an award from MacroGenics, Inc. for a project entitled "A phase 1 first in human open labe dose escalation study of MGD007 a humanized gpA33 x CD3 dual affinity retargeted (DART) protein i patients with relapsed refractory metastatic colorectal carcinoma." Total funding will be $228,876.
Njira L. Lugogo of Pulmonary, Allergy, and Critical Care Medicine has received an award from GlaxoSmithKline for a project entitled "GSK Study 201312, Multi-centre Open Label, Mepolizumab." Total funding will be $394,829.
Neil R. MacIntyre of Pulmonary, Allergy, and Critical Care Medicine has received an award from the COPD Foundation Inc for a project entitled "COPDGene Foundation Project." Total funding will be $2,125.[/tab][/tabs]